Search Results

There are 6239931 results for: content related to: Levodopa-responsive parkinsonism associated with hydrocephalus

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Article first published online : 6 JUN 2014, DOI: 10.1002/mds.25914

  3. Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease

    Movement Disorders

    Volume 21, Issue 11, November 2006, Pages: 1879–1891, Naomi P. Visanji, Jordi Gomez-Ramirez, Tom H. Johnston, Donna Pires, Valerie Voon, Jonathan M. Brotchie and Susan H. Fox

    Article first published online : 7 SEP 2006, DOI: 10.1002/mds.21073

  4. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Article first published online : 28 MAY 2008, DOI: 10.1002/mds.22133

  5. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Article first published online : 24 APR 2007, DOI: 10.1002/mds.21535

  6. Abstracts

    Movement Disorders

    Volume 29, Issue S2, November 2014, Pages: S13–S101,

    Article first published online : 26 NOV 2014, DOI: 10.1002/mds.26090

  7. Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 642–650, Susan H. Fox, Brian Henry, Micheal P. Hill, David Peggs, Alan R. Crossman and Jonathan M. Brotchie

    Article first published online : 16 JUL 2001, DOI: 10.1002/mds.1148

  8. Longitudinal study of levodopa in Parkinson's disease: Effects of the advanced disease phase

    Movement Disorders

    Volume 28, Issue 4, April 2013, Pages: 476–481, Ganesvaran Ganga, Jane E. Alty, Benjamin G. Clissold, Craig D. McColl, Katrina A. Reardon, Mark Schiff and Peter A. Kempster

    Article first published online : 6 FEB 2013, DOI: 10.1002/mds.25335

  9. Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease

    Movement Disorders

    Volume 28, Issue 10, September 2013, Pages: 1398–1406, Maryka Quik, Archana Mallela, Jason Ly and Danhui Zhang

    Article first published online : 8 JUL 2013, DOI: 10.1002/mds.25594

  10. The course of dyskinesia induction by different treatment schedules of levodopa in Parkinsonian rats: Is continuous dopaminergic stimulation necessary?

    Movement Disorders

    Volume 23, Issue 7, 15 May 2008, Pages: 950–957, Christos Tsironis, Marios Marselos, Angelos Evangelou and Spiridon Konitsiotis

    Article first published online : 28 APR 2008, DOI: 10.1002/mds.21630

  11. Poster session 2, Abstracts 345–694

    Movement Disorders

    Volume 19, Issue S9, 2004, Pages: S129–S244,

    Article first published online : 10 MAY 2004, DOI: 10.1002/mds.20176

  12. Dyskinesia Induced by Levodopa and Dopamine Agonists in Patients with Parkinson's Disease

    Drug Induced Movement Disorders, Second Edition

    John G. Nutt, Matthew A. Brodsky, Pages: 313–350, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753217.ch13

  13. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

    Movement Disorders

    Volume 16, Issue 3, May 2001, Pages: 448–458, J. Eric Ahlskog and Manfred D. Muenter

    Article first published online : 9 MAY 2001, DOI: 10.1002/mds.1090

  14. Levodopa

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S23–S37,

    Article first published online : 29 JUL 2002, DOI: 10.1002/mds.5558

  15. Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease

    Movement Disorders

    Volume 17, Issue 6, November/December 2002, Pages: 1180–1187, Susan H. Fox, Brian Henry, Michael Hill, Alan Crossman and Jonathan Brotchie

    Article first published online : 25 JUL 2002, DOI: 10.1002/mds.10289

  16. Milestones in Parkinson's disease therapeutics

    Movement Disorders

    Volume 26, Issue 6, May 2011, Pages: 1072–1082, Olivier Rascol, Andres Lozano, Matthew Stern and Werner Poewe

    Article first published online : 27 MAY 2011, DOI: 10.1002/mds.23714

  17. Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics

    Movement Disorders

    Peter A. LeWitt

    Article first published online : 1 DEC 2014, DOI: 10.1002/mds.26082

  18. Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP-macaque model of Parkinson's disease

    Movement Disorders

    Volume 25, Issue 10, 30 July 2010, Pages: 1379–1390, Tom H. Johnston, Anne van der Meij, Jonathan M. Brotchie and Susan H. Fox

    Article first published online : 22 MAR 2010, DOI: 10.1002/mds.23069

  19. Levodopa-induced hyperactivity in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

    Movement Disorders

    Volume 22, Issue 1, January 2007, Pages: 99–104, Anthony P. Nicholas

    Article first published online : 28 NOV 2006, DOI: 10.1002/mds.21235

  20. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease

    Movement Disorders

    Volume 24, Issue 7, 15 May 2009, Pages: 993–1000, David Devos and for the French DUODOPA Study Group

    Article first published online : 27 FEB 2009, DOI: 10.1002/mds.22450